GlassScriptPhysician profile
Haley Umapathy
NPI 1659022929
$3,219.74
in general payments reported to CMS, 2019-2025
13 companies · $2,891 in 2025
The $2,891 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $329 · 2025: $2,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,545 · Travel and Lodging: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,544.77 |
| Travel and Lodging | $674.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,102.55 | 2024-2025 | Interstim, Intellis Adaptivestim |
| Biotronik Nro, INC. | $1,041.24 | 2025 | Prospera |
| Bayer Healthcare Pharmaceuticals INC. | $195.86 | 2025 | |
| Accord Healthcare, INC. | $167.33 | 2025 | |
| Janssen Biotech, INC. | $145.21 | 2025 | Carvykti, Rybrevant |
| Boston Scientific Corporation | $134.49 | 2025 | Intracept Rf Probe |
| Sumitomo Pharma America, INC. | $128.31 | 2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $125.17 | 2025 | |
| Ferring Pharmaceuticals INC. | $58.47 | 2025 | Adstiladrin |
| Endo USA, INC. | $45.63 | 2025 | Aveed, Xiaflex |
| Tolmar, INC. | $31.07 | 2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $25.14 | 2025 | |
| Progenics Pharmaceuticals, INC. | $19.27 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Umapathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.